<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0401220</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6459</journal-id>
<journal-id journal-id-type="nlm-ta">Phys Med Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Phys Med Biol</journal-id>
<journal-title-group>
<journal-title>Physics in medicine and biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0031-9155</issn>
<issn pub-type="epub">1361-6560</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28657906</article-id>
<article-id pub-id-type="pmc">5557376</article-id>
<article-id pub-id-type="doi">10.1088/1361-6560/aa7c55</article-id>
<article-id pub-id-type="manuscript">NIHMS892416</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Radiogenomics and Radiotherapy Response Modeling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>El Naqa</surname>
<given-names>Issam</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerns</surname>
<given-names>Sarah L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coates</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Speers</surname>
<given-names>Corey</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>West</surname>
<given-names>Catharine M.L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosenstein</surname>
<given-names>Barry S.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ten Haken</surname>
<given-names>Randall K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA</aff>
<aff id="A2">
<label>2</label>Department of Radiation Oncology, University of Rochester, Rochester, NY, USA</aff>
<aff id="A3">
<label>3</label>Department of Oncology, University of Oxford, Oxford, UK</aff>
<aff id="A4">
<label>4</label>Division of Cancer Sciences, Manchester Academic Health Science Centre, Christie Hospital NHS Trust, University of Manchester, Manchester, UK</aff>
<aff id="A5">
<label>5</label>Departments of Radiation Oncology and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>62</volume>
<issue>16</issue>
<fpage>R179</fpage>
<lpage>R206</lpage>
<!--elocation-id from pubmed: 10.1088/1361-6560/aa7c55-->
<abstract>
<p id="P1">Advances in patient-specific information and biotechnology have contributed to a new era of computational medicine. Radiogenomics has emerged as a new field that investigates the role of genetics in treatment response to radiation therapy. Radiation oncology is currently attempting to embrace these recent advances and add to its rich history by maintaining its prominent role as a quantitative leader in oncologic response modeling. Here, we provide an overview of radiogenomics starting with genotyping, data aggregation, and application of different modeling approaches based on modifying traditional radiobiological methods or application of advanced machine learning techniques. We highlight the current status and potential for this new field to reshape the landscape of outcome modeling in radiotherapy and drive future advances in computational oncology.</p>
</abstract>
<kwd-group>
<kwd>Radiogenomics</kwd>
<kwd>outcome modeling</kwd>
<kwd>tumor control</kwd>
<kwd>normal tissue toxicity</kwd>
<kwd>machine learning</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>